Point of View
Intellectual Property · R&D Strategy · Market Intelligence
Most Large R&D Organizations Are Sitting On a Second Company They Don't Know They Own
Technology developed, patented, and shelved has real commercial value in markets nobody on the original team was ever positioned to see. The reason it stays hidden isn't that the value doesn't exist. It's that finding it isn't anyone's job.
Jan 2026
Points of View is Vaxa's opinion column. Each article states a position on a question where reasonable people disagree — and makes the argument for that position directly.
VAXA POINT OF VIEW
Most large R&D organizations are sitting on a second company they don't know they own — technology developed, patented, and shelved that has real commercial value in a market nobody on the original team was ever positioned to see. The reason it stays hidden isn't that the value doesn't exist. It's that finding it isn't anyone's job.
Pattern
Studies of patent commercialization consistently find that up to 90% of patents never result in a product or service reaching market, and separate research puts the share that never generate a single dollar of licensing revenue as high as 97%. This holds even at organizations built specifically to commercialize research. Stanford's own technology licensing office — widely regarded as one of the most effective in the world — has historically declined to even file a patent unless the invention is projected to generate at least $100,000 a year in royalties. That filter exists because most inventions, even at a world-class research institution, are not worth pursuing as filed. The ones that are worth pursuing are frequently missed anyway, simply because nobody with the right cross-industry view was looking at the right time.
Hidden
Studies of patent commercialization consistently find that up to 90% of patents never result in a product or service reaching market, and separate research puts the share that never generate a single dollar of licensing revenue as high as 97%. This holds even at organizations built specifically to commercialize research. Stanford's own technology licensing office — widely regarded as one of the most effective in the world — has historically declined to even file a patent unless the invention is projected to generate at least $100,000 a year in royalties. That filter exists because most inventions, even at a world-class research institution, are not worth pursuing as filed. The ones that are worth pursuing are frequently missed anyway, simply because nobody with the right cross-industry view was looking at the right time.
The value was never the question. The question was always who was actually looking for it — and inside most R&D organizations, the honest answer is no one.
Requirements
Surfacing dormant technology with real commercial value is not a single skill. It requires an honest, systematic inventory and valuation of what already exists in the portfolio — the kind of disciplined analysis most organizations only apply to active development, not to the shelf. It requires the ability to look at a given technology's underlying capability and ask, seriously, which industries entirely outside the one it was built for might need exactly what it does — a foresight exercise, not a sales exercise, because the buyer is rarely obvious from inside the originating industry. And because both the technology landscape and the adjacent-industry landscape keep moving, it requires ongoing tracking rather than a one-time audit — the difference between finding an opportunity once and knowing when a new one opens.
Few organizations have all three of these functioning together, pointed at the same problem, on a continuous basis. That gap — not a lack of underlying value — is the actual reason so much of this stays on the shelf.
Implication
For most large R&D organizations, the honest answer to that question is currently no one — not because the function is missing, but because it was never assigned. That is a solvable gap, not an unsolvable one. Closing it does not require a bigger R&D budget. It requires someone applying IP analysis, cross-industry foresight, and continuous monitoring to a portfolio that has, in most organizations, never been looked at that way before.
The Question to Ask
If your organization's most valuable dormant technology were sitting in the portfolio right now, whose job would it actually be to find it?